BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 37012443)

  • 1. Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges.
    Dutta S; Hornung S; Taha HB; Bitan G
    Acta Neuropathol; 2023 May; 145(5):515-540. PubMed ID: 37012443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles and Neurodegenerative Diseases.
    Hill AF
    J Neurosci; 2019 Nov; 39(47):9269-9273. PubMed ID: 31748282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
    Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
    Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges.
    Hornung S; Dutta S; Bitan G
    Front Mol Neurosci; 2020; 13():38. PubMed ID: 32265650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.
    Ramirez SH; Andrews AM; Paul D; Pachter JS
    Fluids Barriers CNS; 2018 Jul; 15(1):19. PubMed ID: 29960602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of extracellular vesicles in neurodegenerative diseases.
    Vinaiphat A; Sze SK
    Expert Rev Mol Diagn; 2019 Sep; 19(9):813-824. PubMed ID: 31429341
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracellular vesicles- crucial players in human pregnancy.
    Paul N; Sultana Z; Fisher JJ; Maiti K; Smith R
    Placenta; 2023 Sep; 140():30-38. PubMed ID: 37531747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.
    de Freitas RCC; Hirata RDC; Hirata MH; Aikawa E
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia-derived extracellular vesicles in Alzheimer's Disease: A double-edged sword.
    Trotta T; Panaro MA; Cianciulli A; Mori G; Di Benedetto A; Porro C
    Biochem Pharmacol; 2018 Feb; 148():184-192. PubMed ID: 29305855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Role of Exosome in Neurodegenerative Diseases: A Review Study.
    Sheykhhasan M; Heidari F; Farsani ME; Azimzadeh M; Kalhor N; Ababzadeh S; Seyedebrahimi R
    Curr Stem Cell Res Ther; 2024; 19(6):852-864. PubMed ID: 37496136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of extracellular vesicles in the Parkinson's disease - Pathological mediators and biomarkers.
    Zhao Y; Yang G
    Neurochem Int; 2021 Mar; 144():104974. PubMed ID: 33485881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids.
    Vaz M; Soares Martins T; Henriques AG
    J Neurochem; 2022 Nov; 163(4):266-309. PubMed ID: 36156258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles in neurodegenerative diseases.
    Croese T; Furlan R
    Mol Aspects Med; 2018 Apr; 60():52-61. PubMed ID: 29137922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.
    Leggio L; Paternò G; Vivarelli S; L'Episcopo F; Tirolo C; Raciti G; Pappalardo F; Giachino C; Caniglia S; Serapide MF; Marchetti B; Iraci N
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32948090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles in CNS Developmental Disorders.
    Gomes AR; Sangani NB; Fernandes TG; Diogo MM; Curfs LMG; Reutelingsperger CP
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances on Extracellular Vesicles in Central Nervous System Diseases.
    Jin T; Gu J; Li Z; Xu Z; Gui Y
    Clin Interv Aging; 2021; 16():257-274. PubMed ID: 33603351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.
    Taha HB; Ati SS
    CNS Neurosci Ther; 2023 Dec; 29(12):3741-3755. PubMed ID: 37416941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin.
    Younas N; Fernandez Flores LC; Hopfner F; Höglinger GU; Zerr I
    Transl Neurodegener; 2022 May; 11(1):28. PubMed ID: 35527262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.